Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $523.42 million. The enterprise value is $320.52 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 158.61 million shares outstanding. The number of shares has increased by 17.46% in one year.
| Current Share Class | 158.61M |
| Shares Outstanding | 158.61M |
| Shares Change (YoY) | +17.46% |
| Shares Change (QoQ) | +4.70% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 61.58% |
| Float | 113.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.75 |
| Forward PS | 108.60 |
| PB Ratio | 3.06 |
| P/TBV Ratio | 3.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 52.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.09 |
| Quick Ratio | 5.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.51% and return on invested capital (ROIC) is -38.85%.
| Return on Equity (ROE) | -55.51% |
| Return on Assets (ROA) | -28.85% |
| Return on Invested Capital (ROIC) | -38.85% |
| Return on Capital Employed (ROCE) | -47.10% |
| Weighted Average Cost of Capital (WACC) | 9.37% |
| Revenue Per Employee | $87,685 |
| Profits Per Employee | -$1.09M |
| Employee Count | 73 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.51% in the last 52 weeks. The beta is 0.94, so ACRS's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +35.51% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 4.54 |
| Relative Strength Index (RSI) | 35.98 |
| Average Volume (20 Days) | 2,760,419 |
Short Selling Information
The latest short interest is 11.57 million, so 7.30% of the outstanding shares have been sold short.
| Short Interest | 11.57M |
| Short Previous Month | 15.03M |
| Short % of Shares Out | 7.30% |
| Short % of Float | 10.18% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, ACRS had revenue of $6.40 million and -$79.63 million in losses. Loss per share was -$0.59.
| Revenue | 6.40M |
| Gross Profit | -66.00M |
| Operating Income | -90.41M |
| Pretax Income | -79.63M |
| Net Income | -79.63M |
| EBITDA | n/a |
| EBIT | -90.41M |
| Loss Per Share | -$0.59 |
Full Income Statement Balance Sheet
The company has $204.61 million in cash and investments and $1.71 million in debt, with a net cash position of $202.90 million or $1.28 per share.
| Cash & Investments | 204.61M |
| Total Debt | 1.71M |
| Net Cash | 202.90M |
| Net Cash Per Share | $1.28 |
| Equity (Book Value) | 166.80M |
| Book Value Per Share | 1.11 |
| Working Capital | 99.01M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$75.21 million and capital expenditures -$108,000, giving a free cash flow of -$75.32 million.
| Operating Cash Flow | -75.21M |
| Capital Expenditures | -108,000 |
| Depreciation & Amortization | 411,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -75.32M |
| FCF Per Share | -$0.47 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -1,412.40% |
| Pretax Margin | -1,244.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.46% |
| Shareholder Yield | -17.46% |
| Earnings Yield | -17.75% |
| FCF Yield | -14.05% |
Analyst Forecast
The average price target for ACRS is $9.82, which is 197.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.82 |
| Price Target Difference | 197.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -10.46% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -1.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.01 |
| Piotroski F-Score | 2 |